Lipocine Inc. — Director's Dealing 2021

Jan 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2020-12-31

Reporting Person: Higuchi John W. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-31	Common Stock	S	1700	$1.345	Disposed	698548	Direct
2020-12-31	Common Stock	S	5000	$1.3534	Disposed	693548	Direct